FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also 'on notice' Provided by Dow Jones Sep 20, 2024, 7:24:00 PM. By Eleanor Laise .

FTC sues drug middlemen over manipulating the insulin market Caremark, Express Scripts and Optum Rx are accused of accepting money from drugmakers in exchange for keeping lower-cost insulin off ...

The filing points out the average cost of a brand-name insulin drug in 1999 was $21, but increased to more than $274 by 2017, an increase of 1,200%.

FTC sues drug middlemen for allegedly inflating insulin prices By Annika Kim Constantino,CNBC • Published September 20, 2024 • Updated on September 21, 2024 at 9:09 am BOOKMARKER ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin. Search Query Show Search. News.

The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen boost their profits while "artificially" inflating costs for ...

The U.S. Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up ...